Current mental healthcare tools are inadequate, leaving tens of millions of people suffering. PTSD healthcare is no exception, characterized by failures to understand and address its root cause.

Our approach is different. With our deep understanding of receptor biology, neuroscience, and translational medicine, we have developed a novel drug discovery platform, which we are using to develop precision medications to treat CNS diseases at the source—the most logical target.